U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.5349A>G (p.Lys1783=) AND not specified

Germline classification:
Likely benign (1 submission)
Last evaluated:
Dec 7, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003489715.1

Allele description [Variation Report for NM_000059.4(BRCA2):c.5349A>G (p.Lys1783=)]

NM_000059.4(BRCA2):c.5349A>G (p.Lys1783=)

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.5349A>G (p.Lys1783=)
HGVS:
  • NC_000013.11:g.32339704A>G
  • NG_012772.3:g.29225A>G
  • NM_000059.4:c.5349A>GMANE SELECT
  • NM_001406719.1:c.5349A>G
  • NM_001406720.1:c.5349A>G
  • NM_001406721.1:c.1910-4854A>G
  • NM_001406722.1:c.425-4854A>G
  • NP_000050.2:p.Lys1783=
  • NP_000050.3:p.Lys1783=
  • NP_001393648.1:p.Lys1783=
  • NP_001393649.1:p.Lys1783=
  • LRG_293t1:c.5349A>G
  • LRG_293:g.29225A>G
  • LRG_293p1:p.Lys1783=
  • NC_000013.10:g.32913841A>G
  • NM_000059.3:c.5349A>G
  • NM_000059.3:c.5349A>G
  • NR_176251.1:n.5548A>G
Molecular consequence:
  • NM_001406721.1:c.1910-4854A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001406722.1:c.425-4854A>G - intron variant - [Sequence Ontology: SO:0001627]
  • NR_176251.1:n.5548A>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_000059.4:c.5349A>G - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001406719.1:c.5349A>G - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001406720.1:c.5349A>G - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV004241876Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)		Likely benign
(Dec 7, 2023) 		germlineclinical testing

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV004241876.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: BRCA2 c.5349A>G alters a non-conserved nucleotide resulting in a synonymous change. The variant was absent in 250546 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.5349A>G in individuals affected with Hereditary Breast And Ovarian Cancer Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 1, 2024